BridgeMD
New treatment option for Alcohol Drinking Related Problems
Official title Co-occurence of Mental Illness and Problematic Alcohol Use: an Internet-based Cognitive Behavior Therapy Intervention
ClinicalTrials.gov ID: NCT06789250
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if internet-based cognitive behavior therapy (ICBT ) works to treat co-occurent of problematic alcohol use and mental illness including mild to moderate symptoms of either depression, anxiety, stress or disturbed sleep. The main questions the study aims to answer are: Does the ICBT program lower the self-rated suffering from mental illness?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- AUDIT ≥ 6 points for women and ≥ 8 points for men
- Symptoms of depression, anxiety disorder and/or stress-related illness
- Adequate ability to speak, read and write Swedish
- Having access to the internet and a smartphone, computer or other device.
You likely can't join if
- Ongoing psychological treatment.
- Ongoing medication for AUD
- Recent changes (within the past three months) in psychiatric medication or planned changes during the treatment period. New medication prescribed...
- Severe psychiatric disorders based on a Mini-International Neuropsychiatric Interview (MINI) interview and reported medical history
- Severe medical conditions that may impede participation in the study
- Severe cognitive impairment
See the full eligibility criteria
- Age ≥18 years
- AUDIT ≥ 6 points for women and ≥ 8 points for men
- Symptoms of depression, anxiety disorder and/or stress-related illness
- Adequate ability to speak, read and write Swedish
- Having access to the internet and a smartphone, computer or other device.
- Ongoing psychological treatment.
- Ongoing medication for AUD
- Recent changes (within the past three months) in psychiatric medication or planned changes during the treatment period. New medication prescribed during the study shall be reported but will not lead to exclusion
- Severe psychiatric disorders based on a Mini-International Neuropsychiatric Interview (MINI) interview and reported medical history
- Severe medical conditions that may impede participation in the study
- Severe cognitive impairment
- Current suicidality
- Severe alcohol addiction where specialized treatment is more appropriate
- Risk for severe alcohol withdrawal symptoms with a need for medical treatment. Participation is possible after completing alcohol withdrawal treatment within the ordinary health-care system, accessible to the Swedish...
- Substance use disorder, other than alcohol or nicotine, within the past six months.
The study team makes the final eligibility decision.
Where it's taking place
- Linköping, Sweden
- Linköping, Östergötland County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Linköping, Sweden; Linköping, Östergötland County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.